What Sydney Neuroimaging Analysis Centre does

Sydney Neuroimaging Analysis Centre (SNAC) is a private Australian medical-imaging AI company founded in 2012 and co-located within the University of Sydney's Brain and Mind Centre. The company builds and commercializes regulatory-cleared deep-learning software for quantitative analysis of brain MRI and CT scans, with its flagship iQ-solutions™ platform (FDA 510(k)-cleared, TGA Class II) offering sub-millimetre-precision segmentation and longitudinal tracking of brain structures, lesions, and atrophy via modules iQ-MS™ (multiple sclerosis monitoring) and iQ-COG™ (cognitive dysfunction and dementia assessment). Its second core product, VeriScout™, is a TGA Class IIb-approved AI solution that automatically detects and triages cerebral haemorrhage on non-contrast head CT. Both run over Torana™, a vendor-neutral DICOM/HL7 medical-imaging gateway that integrates the outputs directly into customer PACS/RIS workflows with no additional radiologist clicks.

SNAC operates two distinct but complementary revenue streams. The first is a subscription SaaS/SaMD model in which iQ-Solutions and VeriScout are deployed enterprise-wide across radiology networks and hospitals (I-MED Radiology Network across 100+ clinics, Qscan Group, St Vincent's Hospital Sydney, North Shore Radiology, Synergy Radiology). The second is a central MRI reading and imaging-clinical-trial services business for pharmaceutical sponsors (Biogen, Roche, Novartis, Sanofi, Clene Nanomedicine) running Phase II-IV trials in MS, dementia, and neurodegenerative disease, delivered under ISO 9001, ISO 13485, and CFR 21 Part 11 compliance. The company is co-led by co-founder and COO Dr Chenyu (Tim) Wang and CRO Prof. Michael Barnett, with a CCO (John Moulden) added to drive commercial expansion.

Name

Sydney Neuroimaging Analysis Centre

Legal name

Sydney Neuroimaging Analysis Centre Pty Ltd

Website

https://snac.com.au

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Sydney Neuroimaging Analysis Centre (SNAC) builds FDA- and TGA-cleared AI software (iQ-solutions, VeriScout, Torana) for quantitative brain MRI and CT analysis, serving Australian radiology networks, hospitals, and pharmaceutical clinical trial sponsors.

Ownership category

akta.pro rank

Product category

Medical Imaging AI Software

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690), Computer Systems Design and Related Services (54151)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000), Services-Computer Programming Services (7371)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI)

Keywords

• AI neuroimaging analysis
• Brain MRI quantification
• Medical imaging software
• Clinical trial imaging services
• PACS imaging integration

Headquarters

HQ city

Camperdown

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure

Revenue model

1. iQ-Solutions SaaS/SaMD Subscriptions: AI-powered neuroimaging analysis software delivered as a subscription-based SaaS model, deployed enterprise-wide across radiology networks and hospitals. Revenue generated through per-clinic or per-scan subscription fees.
2. Clinical Trial Imaging Services: Full suite of regulatory-compliant central MRI reading services for Phase II-IV pharmaceutical clinical trials. Includes trial design consultation, site certification, scan management, and reporting. Revenue from study contracts with pharma sponsors.
3. Torana™ Medical Imaging Gateway: Class I medical device software for medical image management, routing and databasing. Can be sold as a licensed product with ongoing support and maintenance fees.
4. Consulting and Professional Services: Imaging informatics consulting, custom pipeline development, biomarker creation for investigator-driven studies, and education/training workshops for industry partners.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

SNAC develops and sells AI-powered software as a medical device (SaMD) for quantitative neuroimaging analysis, including iQ-solutions for brain MRI quantification (iQ-MS for multiple sclerosis and iQ-COG for cognitive dysfunction/dementia), VeriScout for CT cerebral hemorrhage detection, and Torana as a medical imaging gateway for PACS/RIS integration. The company also provides central MRI reading services for Phase II-IV pharmaceutical clinical trials, plus imaging informatics consulting, research services, and education/training.

Product overview

SNAC offers a unified platform-plus-modules architecture centered on AI-powered medical imaging analysis. The core offering is iQ-solutions™ (comprising iQ-MS™ for MS monitoring and iQ-COG™ for cognitive assessment), which delivers quantitative MRI analysis through PACS-integrated workflows. This is complemented by VeriScout™ for CT hemorrhage detection and Torana™ as the underlying medical imaging gateway that enables all products to integrate with hospital PACS, RIS, and research systems. The portfolio covers the full spectrum from clinical trials central reading services to direct clinical deployment across radiology networks.

Differentiator

Problem solved

Functional benefit

Brands

• iQ-solutions: AI-powered quantitative brain MRI analysis software platform (FDA 510(k) cleared, TGA Class II/IIb listed) with iQ-MS and iQ-COG modules for monitoring multiple sclerosis and cognitive dysfunction.
• Torana
• VeriScout

Products and services

• iQ-solutions FDA 510(k)-cleared and TGA Class II AI-powered software platform providing submillimeter-precision quantitative analysis of brain MRI scans for monitoring chronic neurological diseases. Delivered as a 'zero-click' solution integrated with clinical PACS workflows.
• iQ-MS AI module for multiple sclerosis monitoring providing automated lesion segmentation, quantification of white matter hyperintensities, and longitudinal tracking of brain volume changes against normative data.
• iQ-COG

Quantifiable outcome

• iQ-Solutions achieves 93.3% sensitivity vs 58.3% for standard radiology reports in detecting active MS disease (new/enlarging lesions) in a multicentre real-world cohort of 397 MRI scan pairs
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability10 records

Feature8 records

Partnerships

15 partnerships are on record, tiered core, secondary and minor.

• I-MED Radiology NetworkcoreStrategic or Co-development Partner · 13 May 2026Enterprise deployment of SNAC's iQ-solutions™ platform (iQ-MS™ and iQ-COG™) across I-MED's network of 100+ MRI clinics in Australia. iQ-solutions provides quantitative brain MRI insights complementing I-MED's sub-specialist radiologist expertise for assessment and monitoring of MS and cognitive dysfunction.
• Qscan GroupcoreStrategic or Co-development Partner · 4 December 2025Enterprise deployment of iQ-Solutions (iQ-MS and iQ-COG) across Qscan Group's radiology network, enabling consistent quantitative brain MRI insights for clinicians and referrers across Qscan's sites. Qscan Group is a premier Australian neuroimaging centre.
• Qscan Group (Gold Coast)secondaryStrategic or Co-development Partner · 24 February 2025Initial deployment of iQ-solutions at Qscan's premier neuroimaging centre on the Gold Coast, marking a step forward in advanced imaging technology for chronic neurological disease monitoring.
• North Shore Radiology and Nuclear MedicinesecondaryStrategic or Co-development Partner · 13 February 2025Partnership to complement state-of-the-art MRI at North Shore Radiology with SNAC's AI-based precision brain analysis tool iQ-Solutions for enhanced monitoring and management of MS and cognitive conditions.
• St Vincent's Hospital SydneycoreStrategic or Co-development Partner · 10 June 2022Multi-year strategic collaboration for development and deployment of AI-based solutions for rapid triage of critical imaging abnormalities in emergency departments and enhanced monitoring of chronic neurological disease patients. Leverages complementary resources including AI engineers, radiologists, imaging analysts, and clinical data.
• Synergy RadiologysecondaryStrategic or Co-development Partner · 16 February 2022Multi-year collaboration agreement to integrate SNAC's AI technologies into Synergy Radiology's existing workflows, enhancing diagnostic productivity and precision imaging for neurological disease patients. Synergy Radiology is part of Qualitas Healthcare Group.
• NVIDIAcoreTechnology or Integration · 11 November 2021Co-development of TRANSCEND federated learning platform using NVIDIA Clara Train SDK and CLARA Federated Learning frameworks. Partnership dates to 2017 for quantifiable neuroimaging analysis and expanded in 2020 for multi-centre AI medical imaging platform under MRFF initiative. NVIDIA provides GPU technology and NVFlare federated learning runtime.
• MSBase / University of Sydney Brain and Mind CentrecoreStrategic or Co-development Partner · 1 January 2021Key partner in MSBase Imaging Repository (MSBIR) initiative. SNAC provides iQ-MS analytics, Torana for data retrieval and de-identification, and COEUS for metadata search. MSBIR integrates imaging-clinical data across 10 global sites for MS research, supporting ~850 researchers and ~80,000 patients on MSBase platform.
• University of Sydney Brain and Mind CentrecoreStrategic or Co-development PartnerSNAC is co-located within and deeply collaborates with the University of Sydney's Brain and Mind Centre. The computational neuroscience team provides AI research capabilities. SNAC was co-founded by Professor Michael Barnett from the Brain and Mind Centre. The partnership secured A$2.36M MRFF grant in 2018.
• RocheminorOthersPharmaceutical partner for clinical trials. Roche is listed among SNAC's trusted partners, indicating involvement in clinical trial imaging services.
• GEminorOthersGE (General Electric) is listed among SNAC's trusted partners, indicating collaborative work with major imaging hardware providers.
• NovartisminorOthersPharmaceutical partner for clinical trials. Listed among SNAC's trusted partners.
• BiogenminorOthersPharmaceutical partner for clinical trials in MS and neurological diseases. Listed among trusted partners.
• SanofiminorOthersPharmaceutical partner for clinical trials. Listed among SNAC's trusted partners.
• Clene NanomedicineminorOthersPharmaceutical sponsor for neurodegenerative disease clinical trials. SNAC provided central MRI reading for Clene's clinical development program.

Scale indicators14 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• icometrix: icometrix develops AI-based software (icobrain) for quantitative analysis of brain MRI/CT scans in MS, dementia, and traumatic brain injury. Closest direct peer to SNAC — same product category (neuroimaging AI SaMD), same therapeutic focus (MS, dementia), and same PACS-integrated deployment model to radiology networks and pharma sponsors.
• RapidAI: RapidAI provides AI-powered neuroimaging software for stroke and other neurological conditions, with FDA-cleared products deployed in hospital systems globally. Competes with SNAC's VeriScout in CT-based emergency neuroimaging and serves overlapping radiology/hospital customers.
• Viz.ai: Viz.ai develops AI-powered care coordination and image analysis for stroke and other acute conditions. Competes with SNAC's VeriScout on AI triage of critical brain CT findings and shares the same enterprise SaaS go-to-market to hospital networks.
• Aidoc: Aidoc offers AI-driven clinical decision support across multiple imaging modalities including brain CT for hemorrhage detection. Overlaps with SNAC's VeriScout and broader radiology AI workflow integration via PACS, though Aidoc's portfolio extends beyond neuro.
• Brainomix: Brainomix develops AI-powered imaging biomarkers for stroke and cerebrovascular disease with FDA-cleared and CE-marked products. Direct competitor in the AI brain CT/Stroke imaging space with similar hospital SaaS deployment model.
• Qure.ai: Qure.ai develops AI algorithms for medical imaging, including head CT for hemorrhage detection (qER) and other radiology applications. Competes with SNAC's VeriScout in AI-enabled emergency brain CT interpretation, with global deployment.

Emerging players

• Subtle Medical: Subtle Medical develops AI-powered image enhancement software for MRI and PET imaging, focused on faster acquisition and improved quality. Adjacent to SNAC's MRI workflow solutions, with partial overlap on neuroimaging AI use cases.
• Blackford Analysis: Blackford Analysis provides a centralized AI platform for radiology image analysis, integrating multiple third-party AI algorithms into radiology workflows. Comparable to SNAC's Torana gateway in enabling multi-AI deployment across PACS/RIS systems.

Broad incumbents

• Arterys (Tempus): Arterys (now part of Tempus) developed a cloud-based AI platform for medical imaging including cardiac and lung applications. Comparable as an AI imaging SaaS platform with radiology network deployments, though broader than SNAC's neuro focus.

Regional players

• Median Technologies: Median Technologies provides imaging solutions and AI-based image analysis services for clinical trials and routine clinical practice, primarily serving European and US pharma sponsors. Comparable to SNAC's central reading and clinical trial imaging services business.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sydney-neuroimaging-analysis-centre
• Xx.com/SNAC_AUS

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sydney Neuroimaging Analysis Centre